Stratify Therapeutics

Stratify Therapeutics is a private biotechnology company focused on developing innovative therapeutics for rare diseases. Publicly available information on the company is limited, but multiple sources identify it as a gene therapy- and rare disease-oriented startup led by co-founders Jodi A. Cook and Nora Yang. The company appears to have been organized as Stratify Therapeutics LLC in the United States and has been described as building a portfolio of therapeutics for rare and monogenic diseases. No clearly disclosed clinical-stage assets, marketed products, or detailed pipeline information were identified in public sources reviewed.